Article
Intra-tumour heterogeneity - going beyond genetics.
The FEBS journal - 1 Jun 2016
Caiado Francisco, Silva-Santos Bruno, Norell Håkan
Abstract excerpt
Cancer patients die primarily due to disease recurrence after transient treatment responses. The emergence of therapy-resistant escape variants is fuelled by intra-tumour heterogeneity, underpinned by interference and Darwinian evolution among continuously developing sub-clones in the mutating tumour. Novel cancer cell variants build upon the pre-existing genetic landscape and tumour heterogeneity is often...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
